Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 2, 2000

View Archived Issues

Cell Therapeutics reviews third quarter developments

SangStat strengthens therapeutic focus

HGS and Dow to develop radiolabeled BLyS

Tanox discusses proprietary pipeline at investor conference

Select seeks approval in Canada to begin clinical trials of VeroPulse

AAPS news: pharmacokinetics and metabolism of HI-113 in mice

SB discusses research efforts in the area of 5-HT2C antagonists at AAPS meeting

Pharmacological characterization of novel antiasthmatic agent NIP-520

Karo Bio and Merck & Co. extend ER receptor drug discovery collaboration

Immunomodulatory peptide useful for producing Th1 switch in allergy

P2Y2 receptor agonists show promise for treatment of vaginal dryness

Allergan's novel glaucoma drug nears clinical trials

EMD-221829, a new PDE5 inhibitor: correlation of pharmacokinetics and pharmacodynamics

New Biotransport formulation of etoposide more effective than currently used formulation

PK interactions with doxorubicin and toxicity of MDR modulator LY-335979 reported at AAPS

Enhanced bioavailability of water-insoluble MTP inhibitor achieved with new formulation

Pharmacia files NDA for injectable parecoxib sodium

Clinical improvement seen in patients with undifferentiated spondyloarthropathy treated with subreum

Lanicemine now claimed for treatment of headache

Use of vasopeptidase inhibitors in angina pectoris claimed by BMS

Potent, broad-spectrum erythromycin derivatives prepared at Abbott

Cathepsin inhibitors synthesized at AxyS claimed for osteoporosis, etc.

New amide inhibitors of cytokine and interleukin production from AstraZeneca

Lilly discovers novel polypeptide with potential in obesity Rx

Recently issued patent covers Pfizer's newest sorbitol dehydrogenase inhibitors

Xoma initiates phase I trial with ING-1 monoclonal antibody

ASRM 2000: hormonal effects, safety and pharmacokinetics of abarelix depot-F in endometriosis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Cosmo data positive for first new hair-loss approach in decades
BioWorld
Shares of Cosmo Pharmaceuticals NV rose sharply on Dec. 3 following top-line pivotal phase III data showing a statistically significant and clinically meaningful...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...